Rigel Pharmaceuticals Announced A Multi-year Strategic Development Collaboration To Expand The Evaluation Of Rezlidhia (Olutasidenib) In Acute Myeloid Leukemia And Other Hematologic Cancers, Rigel To Provide $15M In Time-Based Milestone Payments
Benzinga Newsdesk - Dec 8, 2023, 8:06AM